香港股市迎来全面利好交易日，恒生指数大幅攀升1.6%，收于24,590.12点。然而，在市场普遍上涨的背景下，国药控股ADR股价逆势下跌2.2%，报18.72港元。此次下滑终结了该股连续三天的上涨势头。当前股价较其10月7日创下的52周高点23.65港元低21%，凸显相对弱势。与竞争对手相比，国药控股表现逊色；上海复星医药同期跌幅为1.4%。成交量方面，总交易量达700万股，高于50日均值640万股，显示市场活跃度提升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.